chaperone. TF interacts transiently with most nascent cytosolic proteins a nascent chain with minimal average length of~110 residues is synthesized (4) . To test the effect of TF, we expressed wild-type levels of TF in strains 3 and 4 (making strains 7 and 8, respectively) and strains 5 and 6 (making strains 9 and 10). In vivo luciferase activity measurements of strains 7 and 8 indicate no effect of TF on the enhanced efficiency of cisassembly ( fig. S6 ). However, SeRP experiments of strains 9 (yfp-luxB in bicistronic organization with unlabeled luxA) and 10 (yfp-luxA in bicistronic organization with unlabeled luxB) reveal that TF does affect cotranslational interactions of the nascent luciferase subunits ( Fig. 2A) . Comparison of the cotranslational interaction of YFPLuxB with nascent LuxA in the absence (strain 5) and presence (strain 9) of TF shows that TF efficiently suppresses interactions of YFP-LuxB with nascent LuxA (Fig. 2A, left) . In contrast, TF delays but does not block the interaction of YFP-LuxA with nascent LuxB, shifting the minimal length of nascent LuxB that is required for cotranslational interaction from 90 to 152 residues ( Fig. 2A, right) , without affecting the~20-fold enrichment of ribosome footprints near the end of luxB translation. We infer that TF chaperone activity shields nascent LuxB from premature interactions with LuxA but allows the exposure of the dimerization fold for timely interactions with LuxA molecules in the vicinity of the ribosome.
The luciferase heterodimer interface is large (residues 17 to 161 in LuxA and 11 to 163 in LuxB). Extensive contacts occur via a parallel four-helix bundle formed by helices a2 and a3 from either subunit (residues 55 to 65 and 83 to 97 in LuxB) ( Fig. 2B and table S1) (2) . Given the length of the ribosomal tunnel, a2 and a3 of nascent LuxB will be fully exposed after translation of the first 127 codons; the complete subunit interface of LuxB will be exposed after translation of codon 193. In the absence of TF, initial contacts of nascent LuxB with LuxA are established upon emergence of helix a3 (translation of the first 120 codons). With TF present, we detected initial interactions of nascent LuxB with LuxA only upon exposure of~152 N-terminal LuxB residues (translation of the first 182 codons), constituting nearly the complete subunit interface ( Fig. 2A, right) .
We conclude that association of fully synthesized LuxA with nascent LuxB requires ribosomeassociated exposure of critical structural elements of the dimerization interface on LuxB. TF further increases the specificity of subunit interactions by preventing association of LuxB with nascent LuxA and premature association of LuxA with short nascent chains of LuxB, but it selectively allows LuxA association with long nascent chains of LuxB, exposing the complete dimer interface. We propose that TF engagement with nascent LuxA prevents premature interactions of the latter with LuxB and effectively promotes timely delivery of full-length LuxA to nascent LuxB. Likewise, during the early stages of translation, interaction of TF with nascent LuxB may protect the nascent subunit from incorrect and premature folding and interactions, until the assemblycompetent part of LuxB is sufficiently exposed at the ribosomal surface for productive interaction with LuxA. Our results provide proof of principle for organized and regulated protein assembly in bacteria and validate previous observations that suggested translational coupling affects protein complex assembly (6) . The SeRP data provided for bacterial luciferase are consistent with the concept that a fully synthesized subunit encoded by an upstream gene interacts with the nascent subunit encoded by the downstream gene of an operon. Assembly, which is considered a final, posttranslational step in the generation of oligomeric proteins, emerges as a process that is physically and kinetically coupled to the fundamental processes of protein biogenesis, folding, and translation. Our findings add a further dimension to the concept of the operon, originally defined by Jacob and Monod as a genetic unit for coordinated regulation of transcription (7) . The genetic organization into operons of genes for products destined for assembly into protein complexes determines local concentration of subunits and crucial timing of assembly. Anion exchanger 1 (AE1), also known as band 3 or SLC4A1, plays a key role in the removal of carbon dioxide from tissues by facilitating the exchange of chloride and bicarbonate across the plasma membrane of erythrocytes. An isoform of AE1 is also present in the kidney. Specific mutations in human AE1 cause several types of hereditary hemolytic anemias and/or distal renal tubular acidosis. Here we report the crystal structure of the band 3 anion exchanger domain (AE1 CTD ) at 3.5 angstroms. The structure is locked in an outward-facing open conformation by an inhibitor. Comparing this structure with a substrate-bound structure of the uracil transporter UraA in an inward-facing conformation allowed us to identify the anion-binding position in the AE1 CTD , and to propose a possible transport mechanism that could explain why selected mutations lead to disease. E fficient delivery of oxygen to tissues and the removal of carbon dioxide from the blood are fundamental for respiration. This is principally achieved via the red blood cells or erythrocytes. Anion exchanger 1 (AE1), also known as band 3 or SLC4A1, predominates in the erythrocyte ghost membrane and constitutes 30% of its protein (1). It plays a major role in gas transport. Carbon dioxide generated by metabolic processes in the tissues diffuses into the red blood cells. There it reacts with water in a reversible process catalyzed by carbonic anhydrase II to form HCO 3 -and protons (2) . As the bicarbonate concentration in the erythrocyte increases, the anions are transported by AE1 out into the blood plasma in an electroneutral exchange for chloride ions. With~10 6 AE1 molecules per cell (1) and each single protein transporting 4 × 10 4 to 5 × 10 4 ions per second (3, 4), transport is extremely fast, and~90% of the CO 2 is taken from the tissues to the lungs as the more soluble form of bicarbonate. Within the erythrocyte, the net result is the accumulation of protons from the hydration of CO 2 . As a result of the Bohr effect, the low pH causes hemoglobin to release oxygen, which can then diffuse into the tissues. When the blood reaches the lungs, the process is reversed and CO 2 is exhaled.
Erythrocyte AE1 is the most abundant and widely studied anion exchanger, but AE1 and its close homologs AE2 and AE3 are found in diverse tissues (5, 6) , playing important roles in the regulation of intracellular pH, cell volume, and membrane potential through the exchange of HCO 3 -and Cl -. AE1 is highly expressed as an Nterminally truncated form in the kidney, where it is instrumental in the reabsorption of bicarbonate (7). Many morphological and anemic disorders in the erythrocytes, as well as distal renal tubular acidosis in the kidney, are caused by inherited mutations in AE1 (8) .
Human erythrocyte AE1 is a 110-kD glycoprotein. It is built from two domains (9), a cytosolic N-terminal domain (residues 1 to 360) and an integral membrane domain (residues 361 to 911). Anion exchange is catalyzed by the C-terminal domain (10) (11) (12) . However, only the crystal structure of the cytosolic N-terminal domain (13)-which is important as an anchoring point for other proteins, including the scaffolding protein ankyrin (14, 15) and deoxyhemoglobin-has been determined (16, 17) . A wealth of biochemical experiments, including cysteine scanning mutagenesis (18) (19) (20) (21) (22) (23) and N-glycan insertion mutagenesis (24, 25) , have been used to derive topology models of AE1. The only three-dimensional structural information available to date for the transmembrane domain is from electron microscopy (26, 27) , with the best maps at a resolution of 7.5 Å, calculated from two-dimensional crystals (28) . As such, the membrane topology, substrate recognition, and anion-transport mechanism of this fundamental protein remain unclear, and diverse models have been proposed (28) (29) (30) (31) . Here we report the crystal structure at 3.5 Å resolution of the membrane domain of human AE1, locked in an outward-facing open conformation by a covalently bound inhibitor, in complex with a Fab fragment from a monoclonal antibody.
The C-terminal anion exchanger domain of AE1 (AE1 CTD ), with the N terminus cleaved by trypsin, was purified directly from white ghost membranes of human erythrocytes and treated with H 2 DIDS (4,4-diisothiocyanatodihydro-stilbene-2,2-disulfonic acid), a disulfonic stilbene derivative that irreversibly inhibits anion exchangers by covalently binding to the protein and blocking the transport cycle (32, 33) . Two steps were required to obtain well-diffracting crystals. First, the transporter was deglycosylated with N-glycosidase F. Second, the protein was cocrystallized with a monoclonal antibody Fab fragment that binds tightly to a conformational epitope of AE1 CTD . This antibody was selected from a panel of antibodies raised by the inoculation of mice with AE1 CTDdisplaying baculovirus (34) . The structure was solved using MIRAS (multiple isomorphous replacement with anomalous scattering), in combination with noncrystallographic symmetry averaging, and refined at a resolution of 3.5 Å to an R factor of 27.4% and a free R factor of 29.0% (tables S1 and S2) (32 
unit of the crystal contains two dimers of AE1 CTD , with one Fab fragment bound on the outer side of each protomer (figs. S1 and S2).
Each protomer comprises 14 transmembrane segments (TMs) (Fig. 1 ) and has dimensions of about 60 × 60 × 50 Å. The lengths of the individual TMs vary from 18 to 42 Å. Like many other secondary transporters, the structure is built from two repeats inverted in the plane of the membrane ( fig. S3) . In AE1 CTD , the repeat is made of seven TMs, with the third TM of each repeat only partially spanning the membrane before the helical structure unravels. (fig. S3B) .
The inverted repeat units intertwine to form two structural domains separated by a cleft on the extracellular side of the protein (Fig. 1A) . We define these structural domains as the core (TMs 1 to 4 and 8 to 11) and the gate (TMs 5 to 7 and 12 to 14), following the convention of the uracil transporter UraA (35, 36) . Within the core domain, the N termini of the two half-helices (TMs 3 and 10) face one another at a distance of~10 Å, creating the appearance of a continuous helix (Fig. 2 and fig. S2B ).
The overall fold of AE1 is very similar to the structure of UraA (35), although they have only 12% sequence identity, as aligned using the structures ( fig. S4 ). This structural similarity has been previously suggested on the basis of threading combined with mutagenesis experiments (29) . UraA is also made of two seven-TM repeat units that form two domains. As shown in Fig. 2 , the core domains of AE1 CTD and UraA are similar and can be superposed with a RMSD of 1.8 Å for 145 of 268 Ca atoms (1.9 Å for 131 out of 190 Ca atoms when only the TM segments are considered; fig.  S5 ). The gate domains of the two proteins also have the same topology, but it is more difficult to superpose these domains (RMSD of 2.0 Å for only 55 out of 166 Ca atoms) (Fig. 2, C and D, and  fig. S5 ). This is in part because the relative positions of the three pairs of helices (TMs 5 and 12, TMs 6 and 7, and TMs 13 and 14) are different between AE1 and UraA. Given that the gate domains are directly involved in substrate binding, as discussed below, the structural variation could reflect the different substrates of the two proteins.
AE1 CTD is a physiological dimer (37), but dimerization is not necessary for transport (38, 39) . The dimer in the crystal consists of two AE1 CTD monomers with 1092 Å 2 of surface area buried at the interface (32) . The monomers are related by a twofold axis parallel to the membrane normal, consistent with dimer formation in the erythrocyte membrane (Fig. 1B) . There is no obvious difference between the two dimers as observed in the crystal at the current resolution. The interaction between subunits is formed exclusively through residues on the gate domains, including TMs 5, 6, and 7 (Fig. 1B) .
The Fab fragments bind solely to the core domain of each AE1 CTD (figs. S1 and S2). The interactions between AE1 CTD and the Fab are identical for the four molecules of the asymmetric unit. The predominant interactions are between the heavy chain of the Fab and the C-terminal end of TM 3, the following loop, and the loop before TM 8 ( fig. S1) (41), suggesting that the inhibitor does not bind in the same place as the substrate does. Under the H 2 DIDS molecule, the cavity opens out slightly (18 Å) where the N termini of TMs 3 and 10 meet (Fig. 3) . This region has been suggested as a cation selectivity filter (23) . In UraA, uracil binds in the space between the positive dipoles TMs 3 and 10. The uracil interacts with two glutamate residues, one on TM 8 (Glu
241
) and the other on TM 10 (Glu 290 ) ( Fig. 3B ) (35) . In AE1 CTD , Glu 681 and the positively charged Arg 730 take the positions of these two glutamates on TMs 8 and 10, respectively (Fig. 3B) . Both of these residues are conserved in AE1, and anion exchange is lost if either is mutated (19, (42) (43) (44) . The anions may also interact directly with the amide protons at the N termini of TMs 3 and 10 ( Fig. 3B) . Consistent with anion binding in this space, mutagenesis studies indicate that only a conservative mutation to a threonine (30) or cysteine (29) AE1 exhibits modes of transport other than the physiological 1:1 exchange of bicarbonate and chloride ions. It can also conduct anions (46) or cotransport protons to drive the uptake of divalent sulfate (47) or chloride ions (48) . These ions can easily be accommodated in the basic cavity (figs. S7 and S8). Glu 681 on the translocation pathway is a potential proton acceptor during cotransport of H + and SO 4 2-, because modification to an alcohol (Glu681OH) or mutation to a glutamine leads to a highly proton-independent SO 4 2-/Cl -exchange (42, 49, 50) . Specific mutations in the AE1 CTD domain (fig. S10) are related to red cell diseases such as spherocytosis (51), stomatocytosis (52) , and Southeast Asian ovalocytosis (SAO) (53) . Some of these mutations, particularly those leading to spherocytosis, cause misfolding of the protein, whereas others exhibit abnormal transport kinetics. Some of the mutations in the transport domain are listed in table S3 and shown in Fig. 4 and figs. S11 and S12. An increase in membrane permeability to monovalent cations, caused by mutations in AE1, has been observed in a number of human pedigrees with dominantly inherited hemolytic anemia (22, 44, 52) . These mutations mostly occur on the cytoplasmic half of the core domain (Fig.  4) . They include mutation of Arg 730 , the putative bicarbonate-binding residue, to Cys, as well as two other mutations on the half-helix TM 10 (Ser 731 to Pro and His 734 to Arg). The deletion of residues 400 to 408, which leads to SAO, also causes a cation leak in intact red cells (54) . These residues reside at the TM 1 N terminus at the interface with TM 7 of the gate domain (Fig. 4 and  fig. S12 ), and the mutations in the residues would presumably alter the structure of the core domain, as well as the interaction between AE1 CTD and the N-terminal cytoplasmic domain. It is interesting that this deletion may confer protection against cerebral malaria (54) . Fewer mutations have been reported in the gate domain.
The structure of AE1 CTD reported here is in an outward-facing conformation (Figs. 1 and 3 ). AE1 CTD is reported to undergo large conformational changes during transport, in line with the alternating access mechanism (55, 56) . By comparing the outward-facing AE1 CTD structure with a substrate-bound, inward-facing UraA structure (35), we can gain some insight into the transport mechanism (Fig. 3A and fig. S13 ).
The core domains of these two proteins, including the uracil binding site in UraA, are very similar (Fig. 3B and fig. S5 ). The primary difference between the two structures is in the relative positions of the gate and core domains (Fig. 2, C  and D, and fig. S5 ). The rotation of one domain against another as the transporter moves from outward-to inward-facing, as shown in fig. S5 , is similar to the predominant movements observed for other families of transporters, including the LeuT family transporters, to which there is also some structural similarity ( fig. S14) (36, (57) (58) (59) (60) (61) . Figure S13 shows a possible transport mechanism for AE1. Starting from an outward-facing open conformation of the protein, chloride at a high concentration in plasma binds to the anionbinding site. This causes some local conformational changes of the core domain, enabling it to rotate against the gate domain to form the inward-facing structure. At this point, chloride diffuses out and is replaced by bicarbonate to reverse the process. This is consistent with various results from kinetic studies that indicate that chloride and bicarbonate ions share the same binding site (4) . The structure of the human AE1 CTD and the proposed transport mechanism 
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The Papaver rhoeas S determinants confer self-incompatibility to Arabidopsis thaliana in planta Zongcheng Lin,* Deborah J. Eaves, Eugenio Sanchez-Moran, F. Christopher H. Franklin, Vernonica E. Franklin-Tong † Self-incompatibility (SI) is a major genetically controlled system used to prevent inbreeding in higher plants. S determinants regulate allele-specific rejection of "self" pollen by the pistil. SI is an important model system for cell-to-cell recognition and signaling and could be potentially useful for first-generation (F 1 ) hybrid breeding. To date, the transfer of S determinants has used the complementation of orthologs to "restore" SI in close relatives. We expressed the Papaver rhoeas S determinants PrsS and PrpS in Arabidopsis thaliana. This enabled pistils to reject pollen expressing cognate PrpS. Moreover, plants coexpressing cognate PrpS and PrsS exhibit robust SI. This demonstrates that PrsS and PrpS are sufficient for a functional synthetic S locus in vivo. This transfer of novel S determinants into a highly divergent species (>140 million years apart) with no orthologs suggests their potential utility in crop production.
M
any plants are hermaphrodites, with male and female organs in close proximity. Because this risks self-fertilization and undesirable inbreeding depression, many plants use self-incompatibility (SI) as a mechanism to prevent selfing. SI is controlled by an S locus allowing self/nonself recognition between pistil and pollen (1, 2) . SI in Papaver rhoeas is gametophytically controlled and specified by a pistil S determinant, PrsS [P. rhoeas stigma S (3)], and a pollen S determinant, PrpS [P. rhoeas pollen S (4)]. PrsS and PrpS interact to trigger a signaling network in incompatible pollen, resulting in programmed cell death (PCD) (5) (6) (7) (8) . Arabidopsis thaliana is a self-fertile member of the Brassicaceae. Self-compatibility in Arabidopsis originated 
